|
|
|
Volumn 41, Issue 1045, 1999, Pages 11-12
|
|
Celecoxib for arthritis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
FLUCONAZOLE;
FLUINDOSTATIN;
IBUPROFEN;
NAPROXEN;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
UNCLASSIFIED DRUG;
ZAFIRLUKAST;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL TRIAL;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
GASTROINTESTINAL TOXICITY;
HUMAN;
LIVER TOXICITY;
NEPHROTOXICITY;
OSTEOARTHRITIS;
PEPTIC ULCER;
REVIEW;
RHEUMATOID ARTHRITIS;
ABDOMINAL PAIN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
CYCLOOXYGENASE INHIBITORS;
DIARRHEA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
FATTY ACIDS, MONOUNSATURATED;
FLUCONAZOLE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INDOLES;
OSTEOARTHRITIS;
PYRAZOLES;
SULFONAMIDES;
|
|
EID: 0033613823
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (31)
|
|
References (0)
|